Treatment of COVID-19 olfactory dysfunction with olfactory training, palmitoylethanolamide with luteolin, or combined therapy: a blinded controlled multicenter randomized trial.

Arianna Di Stadio,Salvatore Gallina,Salvatore Cocuzza,Pietro De Luca,Angelo Ingrassia,Simone Oliva,Federico Sireci,Angelo Camaioni,Fabio Ferreli,Giuseppe Mercante,Francesca Gaino,Gian Marco Pace,Ignazio La Mantia,Michael J Brenner

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery（2023）

引用 0|浏览3

暂无评分

摘要

1b (Individual Randomized Clinical Trial).

查看译文

关键词

Anosmia, COVID-19, SARS-CoV-2, Coronavirus, Neuroinflammation, Olfactory training, PEA, PEA-LUT, Smell disorders, Palmitoylethanolamide, Luteolin, Randomized trial, Clinical trial, Post-acute sequelae of COVID-19, Hyposmia

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要